SEC Form 4 · accession 0001683168-17-001927
US-China Biomedical Technology, Inc. · UCBB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Goldenrise Development, Inc.
10% Owner
Period of report
Jul 28, 2017
Accepted (ET)
Aug 2, 2017 · 1:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 28, 2017 | S | 12,000,000 | $0.033 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 28, 2017, Goldenrise Development, Inc. (Goldenrise) and Michael Dunn, and assigns, entered into a Stock Purchase Agreement whereby Goldenrise sold an aggregate 12,000,000 restricted common stock shares at a $0.033 cost basis per share. The Closing occurred on July 28, 2017.